Functional characterisation of human cells harbouring a novel t(2p;7p) translocation involving TNS3 and EXOC6B genes

BMC Medical Genetics

Sassan Hafizi²  Sergio Barlati¹  Giuseppe Borsani¹  James R Smith²  Jessica Carter²  Desiree Ludwig² 

[1] Dipartimento di Scienze Biomediche e Biotecnologie, Sezione di Biologia e Genetica, Universita' di Brescia, Brescia, Italy;Institute of Biomedical and Biomolecular Science (IBBS), University of Portsmouth, School of Pharmacy & Biomedical Sciences, St. Michael’s Building, White Swan Road, Portsmouth PO1 2DT, UK

关键词: Cell migration;    Haploinsufficiency;    Chimera;    Translocation;    Exocyst;    Tensin;   

Others  :  1137112
DOI  :  10.1186/1471-2350-14-65

 received in 2012-10-18, accepted in 2013-06-24,  发布年份 2013

【 摘 要 】

Background

Tensin3 is an intracellular cytoskeleton-regulating protein, the loss of which is associated with increased cell motility, as has been observed in some human cancers. A novel chromosomal translocation, t(2;7)(p13;p12), present in a patient with a complex syndromic phenotype, directly involves Tensin3 (TNS3) and EXOC6B genes. This translocation could impair the expression of Tensin3 and ExoC6B proteins, and potentially produce two novel fusion transcripts. In the present study, we have investigated the expression and phenotypic features of these potential products in cultured cells from the proband.

Methods

Skin fibroblasts isolated from the proband as well as an age-matched control were grown in cell culture. Cells were used for quantitative RT-PCR, western blot and immunofluorescent confocal microscopy, which determined Tensin3 gene and protein expression. Phase-contrast and confocal microscopy additionally revealed cellular phenotype differences. A scratch wound assay monitored by live cell imaging measured cellular migration rates.

Results

The levels of Tensin3 at both mRNA and protein levels were lower in proband cells versus control fibroblasts. Proband cells displayed broader and shorter morphologies versus control fibroblasts, and immunofluorescent staining revealed additional Tensin3 expression along cytoskeletal filaments and the cell periphery only in control fibroblasts. In addition, proband fibroblasts showed a significantly higher migration rate than control cells over 24 h.

Conclusions

The phenotypic changes observed in proband cells may arise from TNS3 haploinsufficiency, causing partial loss of full-length Tensin3 protein. These results further expose a role for Tensin3 in cytoskeletal organisation and cell motility and may also help to explain the syndromic features observed in the patient.

【 授权许可】

   
2013 Ludwig et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

【 参考文献 】

• [1]Calderwood DA, Fujioka Y, de Pereda JM, Garcia-Alvarez B, Nakamoto T, Margolis B, McGlade CJ, Liddington RC, Ginsberg MH: Integrin beta cytoplasmic domain interactions with phosphotyrosine-binding domains: a structural prototype for diversity in integrin signaling. Proc Natl Acad Sci USA 2003, 100:2272-2277.
• [2]Hafizi S, Alindri F, Karlsson R, Dahlbäck B: Interaction of Axl receptor tyrosine kinase with C1-TEN, a novel C1 domain-containing protein with homology to tensin. Biochem Biophys Res Commun 2002, 299:793-800.
• [3]Cui Y, Liao YC, Lo SH: Epidermal growth factor modulates tyrosine phosphorylation of a novel tensin family member, tensin3. Mol Cancer Res 2004, 2:225-232.
• [4]Yamashita M, Horikoshi S, Asanuma K, Takahara H, Shirato I, Tomino Y: Tensin is potentially involved in extracellular matrix production in mesangial cells. Histochem Cell Biol 2004, 121:245-254.
• [5]Qian X, Li G, Asmussen HK, Asnaghi L, Vass WC, Braverman R, Yamada KM, Popescu NC, Papageorge AG, Lowy DR: Oncogenic inhibition by a deleted in liver cancer gene requires cooperation between tensin binding and Rho-specific GTPase-activating protein activities. Proc Natl Acad Sci USA 2007, 104:9012-9017.
• [6]Lo SH: Tensin. Int J Biochem Cell Biol 2004, 36:31-34.
• [7]Maeda I, Takano T, Yoshida H, Matsuzuka F, Amino N, Miyauchi A: Tensin3 is a novel thyroid-specific gene. J Mol Endocrinol 2006, 36:R1-R8.
• [8]Martuszewska D, Ljungberg B, Johansson M, Landberg G, Oslakovic C, Dahlbäck B, Hafizi S: Tensin3 is a negative regulator of cell migration and all four tensin family members are downregulated in human kidney cancer. PLoS One 2009, 4:e4350.
• [9]Albasri A, Seth R, Jackson D, Benhasouna A, Crook S, Nateri AS, Chapman R, Ilyas M: C-terminal Tensin-like (CTEN) is an oncogene which alters cell motility possibly through repression of E-cadherin in colorectal cancer. J Pathol 2009, 218:57-65.
• [10]Sakashita K, Mimori K, Tanaka F, Kamohara Y, Inoue H, Sawada T, Hirakawa K, Mori M: Prognostic relevance of Tensin4 expression in human gastric cancer. Ann Surg Oncol 2008, 15:2606-2613.
• [11]Katz M, Amit I, Citri A, Shay T, Carvalho S, Lavi S, Milanezi F, Lyass L, Amariglio N, Jacob-Hirsch J, et al.: A reciprocal tensin-3-cten switch mediates EGF-driven mammary cell migration. Nat Cell Biol 2007, 9:961-969.
• [12]Borsani G, Piovani G, Zoppi N, Bertini V, Bini R, Notarangelo L, Barlati S: Cytogenetic and molecular characterization of a de-novo t(2p;7p) translocation involving TNS3 and EXOC6B genes in a boy with a complex syndromic phenotype. Eur J Med Genet 2008, 51:292-302.
• [13]Hertzog M, Chavrier P: Cell polarity during motile processes: keeping on track with the exocyst complex. Biochem J 2011, 433:403-409.
• [14]Hafizi S, Sernstad E, Swinny JD, Gomez MF, Dahlback B: Individual domains of Tensin2 exhibit distinct subcellular localisations and migratory effects. Int J Biochem Cell Biol 2010, 42:52-61.
• [15]Brooks SA: Functional interactions between mRNA turnover and surveillance and the ubiquitin proteasome system. Wiley Interdisciplinary Reviews - RNA 2010, 1:240-252.
• [16]Nicholson P, Mühlemann O: Cutting the nonsense: the degradation of PTC-containing mRNAs. Biochem Soc Transactions 2010, 38:1615-1620.
• [17]Clark K, Howe JD, Pullar CE, Green JA, Artym VV, Yamada KM, Critchley DR: Tensin 2 modulates cell contractility in 3D collagen gels through the RhoGAP DLC1. J Cell Biochem 2010, 109:808-817.
• [18]Cao X, Voss C, Zhao B, Kaneko T, Li SS-C: Differential regulation of the activity of deleted in liver cancer 1 (DLC1) by tensins controls cell migration and transformation. Proc Natl Acad Sci 2012, 109:1455-1460.
• [19]Kim H, Herrick SR, Lemyre E, Kishikawa S, Salisz JA, Seminara S, MacDonald ME, Bruns GAP, Morton CC, Quade BJ, Gusella JF: Hypogonadotropic hypogonadism and cleft lip and palate caused by a balanced translocation producing haploinsufficiency for FGFR1. J Med Genet 2005, 42:666-672.
• [20]Kong F, Zhu J, Wu J, Peng J, Wang Y, Wang Q, Fu S, Yuan L-L, Li T: dbCRID: a database of chromosomal rearrangements in human diseases. Nucleic Acids Res 2011, 39:D895-D900.
• [21]Chiang MK, Liao YC, Kuwabara Y, Lo SH: Inactivation of tensin3 in mice results in growth retardation and postnatal lethality. Dev Biol 2005, 279:368-377.